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 Abstract 
 
Objective: The objective of this selective EBM review is to determine whether or not topical heat 
patches are more effective at relieving pain associated with dysmenorrhea than OTC NSAIDs 
(Ibuprofen 400 mg PO Q8h or Acetaminophen 500mg PO Q6h) in menstruating women 18 and 
over.   
 
Study Design: Review of three English-language randomized control trials (RCTs) that were 
published in 2001, 2004, and 2012.  
 
Data Sources: Three single-blinded randomized control trials that were found using PubMed  
 
Outcome measured: Dysmenorrhea and any associated pain relief was measured using patient-
reported scales of NRS-10 Pain scale, 6-Point categorical scale, and patient reports of sensual, 
emotional, current, and total pain.  
 
Results: Akin et. al 2001 and 2004 studies found that topical heat patches were associated with 
statistically significant greater reduction in pain associated with dysmenorrhea than oral 
NSAIDs. A 2012 study by Navvabi Rigi, et al., however, showed no statistically significant 
difference in pain reduction in patients that received topical heat versus an oral NSAID. 
 
Conclusions: Some studies have shown that topical heat causes greater pain reduction than oral 
NSAIDs, though the results are inconclusive among all studies. Further studies with larger 
sample sizes and double blinding will be needed to determine the true effectiveness of topical 
heat in treating pain associated with dysmenorrhea versus oral NSAIDs.  
 
Key Words: Heat, dysmenorrhea  
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INTRODUCTION 
Dysmenorrhea is pain associated with a woman’s menstrual cycle that is believed to occur as a 
result of necrosis of the endometrial layer
3
. This paper evaluates 3 RCTs that compare the 
efficacy of topical heat patches as a treatment for dysmenorrhea against traditional OTC 
NSAIDs.  
Dysmenorrhea is a very common problem affecting an estimated 15.8 – 89.5% of women of 
childbearing age worldwide
3
. Rates of dysmenorrhea are higher among adolescents, with 
prevalence and severity generally decreasing with age
3
. Since painful menstrual cramps are such 
a common problem, it is no surprise that dysmenorrhea is a leading cause of absenteeism from 
work and is the most common reason for school absence in young women
4
. In addition to 
causing a disruption in women’s education and work, dysmenorrhea takes a toll on the health 
care system. It is estimated that 14-18% of young women with primary dysmenorrhea seek 
primary care
2
.  
Primary dysmenorrhea is believed to be caused by the myometrial stimulant and vasoconstrictor, 
prostaglandin F2α (PGF2α)4. Traditional methods of treatment have included oral 
contraceptives; prescription and over the counter nonsteroidal anti-inflammatory drugs such as 
Diclofenac, Ibuprofen, Ketoprofen, mecloenamate, and naproxen; dietary supplements such as 
thiamine, fish oil, pyridoxine, magnesium, and vitamin E; Exercise, and acupuncture
4
. In 
addition to these remedies, however, topical heat has long been a home remedy for treatment of 
dysmenorrhea via hot water bottles and electric heating pads. These methods, however, are 
impractical for use throughout the day. With the creation of topical heat pads, it will be 
beneficial to compare their efficacy against OTC NSAIDs in the treatment of dysmenorrhea due 
to the side effects of chronic NSAID use
2
. The traditional treatment, OTC NSAIDs are also 
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known to cause GI inflammation, bleeding, rash, pruritis, tinnitus, dizziness, and renal or hepatic 
complications, making the prospect of using topical heat even more appealing
3
. 
OBJECTIVE 
The objective of this selective EBM review is to determine whether or not topical heat patches 
are more effective at relieving pain associated with dysmenorrhea than OTC NSAIDs (Ibuprofen 
400 mg PO Q8h or Acetaminophen 500mg PO Q6h) in menstruating women 18 and over.   
METHODS 
Specific selection criteria of three randomized control trials (RCTs) were used for this review. 
The population studied was made of menstruating women, aged 18 and over, with a history of 
dysmenorrhea. In each of the 3 RCTs a topical heat patch was used as the intervention. 
Additionally, each RCT compared the pain relief provided by the heat patch against an OTC 
NSAID - either Ibuprofen 400 mg Q8hr or Acetaminophen 500 mg PO Q6h. The outcome 
measured in each of the RCTs was a decrease in symptoms of dysmenorrhea and any associated 
pain relief.  
The studies included in this review were three randomized control trials (RCTs). Keyword 
searches to obtain these articles included the words “heat” and “dysmenorrhea”. Each of the 
articles was published in peer-reviewed journals in English. RCTs for this review were searched 
for by the author of this review via PubMed and were selected based on their relevance to the 
clinical question and patient-oriented outcome. Inclusion criteria included studies that were 
randomized control trials published between 1999 and the present. Studies were excluded if they 
were published before 1999 or included patients less than 18 years of age. Statistics included in 
these 3 RCTS included mean change in pain from baseline, p values, odds ratios, and number 
needed to treat. Table 1 shows the demographics of the included studies.  
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Table 1: Demographics of Included Studies 
Study Type # 
Pts 
Age 
(years) 
Inclusion Criteria Exclusion Criteria W/
D 
Interventions 
Akin, 
2001 
(1) 
RCT 84 21-50  Patients that are non-
pregnant women of 
menstrual age who suffer 
from moderate or severe 
menstrual pain for at least 
4 of their last 6 menstrual 
cycles, at least 18 years of 
age, have a hx of pain 
relief from OTC 
analgesics and use 
reliable forms of 
contraception 
Patients that use any other 
supplemental devices or 
analgesics during the period of 
the study, engage in vigorous 
exercise, excessive alcohol 
consumption, or sexual 
intercourse during the 12 
hours before the study and 
throughout the remainder of 
the study, patients with 
cutaneous lesions involving 
the abdominal wall, 
microvascular disease, 
known/suspected drug or 
alcohol abuse, 
known/suspected 
contraindication to oral 
ibuprofen, and patients that are 
pregnant or recently pregnant   
3 Topical heat 
abdominal 
patches and 
placebo pill VS 
Placebo patch 
and 400 mg 
ibuprofen PO 
Q6hrs 
Akin, 
2004 
(2) 
RCT 367 18-50 Patients that are 
premenopausal women at 
least 18 years of age with 
a medical history, 
physical, and pelvic exam 
consistent with primary 
dysmenorrhea, women 
must also have regular, 
monthly periods over the 
last 9 months with 
moderate or greater 
menstrual pain occurring 
in at least 4 of their last 6 
menstrual cycles as well 
as a consistent use of 
contraception  
Patients with known 
contraindication to use of 
study medication or devices, 
history positive for secondary 
dysmenorrhea, use of 
hormonal contraceptives of IU 
for < 6 months, consistent use 
of medication that could 
interact with the study 
medication, devices, or 
evaluation parameters 
23 Continuous, low-
level, topical heat 
wrap VS. 
Acetaminophen 
500mg PO Q6Hrs 
Nawa
bi 
Rigi, 
2012 
(3) 
RCT 147 18-30 Patients aged 18-30 with 
a hx of dysmenorrhea 
within the first 2 years of 
onset of menstruation 
with regular menstrual 
cycles, good general 
health and a hx of 
moderate to severe 
dysmenorrhea  
Patients with a hx of 
comorbidities (including 
cardiovascular, renal, hepatic, 
pulmonary), coagulopathy, 
DM, anemia, GI bleeding, 
immunological disorder, 
malignancy, psychiatric illness 
requiring therapeutic 
intervention. Also, patients 
with a hx of oral 
contraceptives, smoking, 
pregnancy, professional 
athlete activity, lower 
abdominal scars, BMI > 30, 
and vagnitis, or recent death or 
stress in the family 
42 Iron chip-
containing heat 
wrap VS 
Ibuprofen 400mg 
PO Q8hr PRN  
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 OUTCOMES MEASURED 
Each of the three RCTs used patient-reported pain scales in order to determine the effectiveness 
of the topical heat patch versus the NSAID. The studies, however, varied in methods of rating 
patient-reported pain. Since the patients could not be blinded to which treatment they were 
receiving, each of the studies was single-blinded – meaning the individuals recording data for the 
study were not aware to which group each patient belonged. The two studies by Akin M, et. al 
used both the 6 point categorical scale and the NRS-101 to record patient pain
1,2
. The 6-point 
categorical scales ranges from zero to five – zero representing no pain, while five indicates 
maximum pain
1,2
. The NRS-101 scales ranges from zero to one hundred – zero representing “not 
unpleasant at all” and one hundred representing “the most unpleasant feeling possible for me.”1,2 
The 2012 study by Navvabi Rigi, et. al used the short form of the McGill Pain Questionnaire, 
also known as the SF-MPQ, to measure pain. SF-MPQ consists of 15 descriptors
3
. It has been 
proven to be a reliable tool with proven validity in assessing obstetric patients and has been 
previously used to assess dysmenorrhea
3
. Additionally, the 2012 study used visual analog scales 
ranging from zero to one hundred to rate current pain and from zero to five to rate “overall pain 
severity”3.  
RESULTS 
The 2001 study by Akin et. al was a randomized, placebo and active control “double dummy”, 
parallel study
1
. Eighty-four women were found to be eligible for the study, with eighty one of 
them completing it
1
. The three women who did not complete the study were lost due to their 
failure to follow study protocol – “worst case” analysis was not performed1. Inclusion criteria for 
this study included non-pregnant women of menstrual age who suffered from moderate to severe 
menstrual pain for at least the last 4 of their 6 menstrual cycles; at least 18 years of age; history 
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and physical consistent with primary dysmenorrhea; have a history of pain relief from OTC 
analgesics; reliable contraception including barrier, abstinence, or sterilization
1
. Exclusion 
criteria for this study included use of any supplemental devices or analgesics during the study 
period; vigorous exercise, alcohol consumption, or sexual intercourse during the 12 hours before 
the study and throughout the remainder of the study; cutaneous lesions of the abdominal wall; 
microvascular disease including diabetes; known or suspected drug or alcohol abuse; known or 
suspected contraindication to oral ibuprofen; pregnant or recently pregnant
1
. Women were 
randomly assigned to one of four groups using a computer program
1
. The four groups were as 
follows - heated patch plus ibuprofen, heated patch plus placebo, unheated patch plus ibuprofen, 
and unheated patch plus placebo
1. Women were given “kidney bean-shaped ultra-thin medical 
devices” to adhere to the inside of their underwear on the lower abdominal region which was 
standardized between participants
1
. The patches supply constant heat of 38.9°C for 12 hours, 
after which it was replaced with a new one
1
. Women assigned to ibuprofen groups were given 
400 mg ibuprofen three times a day, six hours apart
1
.  This review is focused on the results of 
two groups – unheated patch plus ibuprofen (n=21) and heated patch plus placebo (n=20) 1. Pain 
relief was recorded every two hours for two days. During the 2 day study, women receiving the 
unheated patch plus placebo had a 35% incidence of complete pain reduction
1
. Women who 
received the experimental treatment of heated patch plus placebo had a statistically significant 
incidence of complete pain relief of 70%, OR 4.3%, p = 0.015 (Table 2)
 1
. Women assigned to 
the unheated patch and ibuprofen group, however, did not have a statistically significant 
incidence of complete pain relief at only 55%, OR 2.3, p = 0.103 (Table 2)
 1
. These numbers 
correlate to a relative benefit increase (RBI) of 0.273, an absolute benefit increase (ABI) of 
0.150, and a number needed to treat (NNT) of 7 (Table 3). This study shows that the use of heat 
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patches alone for treatment of pain associated with dysmenorrhea is statistically significantly 
better than placebo while the use of the traditional use of ibuprofen alone is not. The study 
showed that for every 7 people treated with the heat patch plus placebo, one had more pain relief 
than those treated with the unheated patch plus ibuprofen. Factors that may have affected the 
study include redness at the adhesion site of the patch as well as other symptoms of 
dysmenorrhea including breast fullness and tenderness.  
 
Table 2: 2001 Akin Study: Unheated Patch plus Ibuprofen vs. Heated Patch plus Placebo 
 
Placebo Control Experimental 
Treatment 
unheated patch 
plus placebo 
unheated patch 
plus Ibuprofen 
heated patch 
plus placebo 
Number of patients, N 20 21 20 
Incidence of complete pain 
relief at day 2 
35% 55% 70% 
Odds Ratio, OD --- 2.3 4.3 
p value --- 0.103 0.015 
 
Table 3: 2001 Akin Study: Statistical Analysis of Heated Patch plus Placebo vs. Unheated 
Patch plus Ibuprofen 
CER: 
unheated 
patch plus 
ibuprofen 
EER: heated 
patch plus 
placebo 
Relative Benefit 
Increase, RBI 
Absolute Benefit 
Increase, ABI 
Number needed 
to treat, NNT 
0.55 0.70 0.273 0.15 7 
 
The 2004 study by Akin et. was a randomized, active control, parallel, single-blind, multisite 
study
2
. Three hundred sixty seven women were entered into the initial study with three hundred 
forty four women completing the study
2
. Patients were lost due to violations related to dosing 
compliance as well as study drop out – “worst case” analysis was not performed2. Inclusion 
criteria for the study included premenopausal women of at least 18 years of age; a medical 
history, physical, and pelvic exam consistent with primary dysmenorrhea; women that had 
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regular, monthly periods over the last 9 months with moderate to severe menstrual pain 
occurring in at least 4 of their last 6 menstrual cycles; consistent use of contraception; and 
absences of a history of secondary dysmenorrhea
2
. Exclusion criteria for the study included 
known contraindication to use of the study medications or devices; use of hormonal 
contraception or IUD for less than 6 months; consistent use of medication that could interact 
with the study medication, devices, or evaluation perameters
2
. Women were randomized to one 
of four groups – oral acetaminophen (n = 156), active heat wrap therapy (n = 155), oral placebo 
(n = 22), and inactive heat wrap (n = 24).  The mean age of the women enrolled in the study was 
28.8 years old
2
. Oral acetaminophen dosing was 500 mg twice a day, 8 hours apart
2
. Participants 
were randomly assigned and groups were equally random based on race, daily tobacco use, age, 
height, and baseline pain intensity
2
. The study measured pain relief using a 6 point categorical 
scale at hours 0.5, 1, 1.5, 2, 3, 4, 5, 6, 7, 8, 24, and 48
2
. This study showed that at the end point of 
day 1, the heat wrap group had a statistically significant mean pain relief score (2.48 ± 0.10) 
compared to the oral acetaminophen group (2.17 ± 0.10, p value = 0.015) seen in Table 4
2
. This 
indicates that at the end of the first 8 hour day, the heat wrap group had significantly less pain 
than the acetaminophen group. Additionally, the heat wrap group reported less adverse events 
compared the acetaminophen group, 2 versus 4, respectively (Table 5). The two adverse events 
in the heat wrap group were a mild conjunctivitis and moderate application site reaction
2
. The 
four adverse events in the acetaminophen group were moderate head ache, moderate rhinitis, 
moderate respiratory infection, and severe anxiety
2
.  
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Table 4: 2004 Akin Study: Acetaminophen vs. Heat Wrap  
 
Control Experimental 
Treatment Acetaminophen Heat Wrap 
Mean pain relief from baseline 2.17 2.48 
standard deviation 0.1 0.1 
p value 0.015 
 
 
Table 5: 2004 Akin Study: Adverse Events  
Control Experimental 
Acetaminophen Heat Wrap 
moderate Head ache mild conjunctivitis 
moderate rhinitis moderate application site reaction 
moderate respiratory infection --- 
severe anxiety --- 
 
The 2012 study by Navvabi Rigi, et. al was a randomized control trial with blind raters
3
. 186 
women were assessed for eligibility in the study with 39 women being excluded for not meeting 
inclusion criteria
3
. Inclusion criteria included age 18-30, history of dysmenorrhea within the first 
2 years of onset of menstruation, regular menstrual cycles, “good” general health, and a history 
of moderate to severe dysmenorrhea
3
. Exclusion criteria for this study included history of 
cardiovascular, renal, hepatic or pulmonary comorbidities; history of oral contraceptives, 
smoking, pregnancy, professional athlete activity, lower abdominal scars, BMI > 30, vaginits, or 
recent death or stress in the family
3
. The remaining 150 women were randomly assigned to one 
of two groups – ibuprofen ( n = 75) and heat patch ( n = 75) 3. Three women of the heat patch 
group were lost because they did not receive the allocated intervention – worst case analysis was 
not performed
3
. There were no statistically significant differences among the two groups in 
respect to marital status, socio-economic status, BMI, or abdominal circumference
3
. The dose of 
ibuprofen given to the women in the ibuprofen group was 400mg by mouth every 8 hours as 
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needed for pain
3
. In this study, current severity of pain was measured on a 0-100 scale by 
patients. This study shows that when “current pain” was measured at hour 8 of treatment, the 
ibuprofen group had a slightly lower, though statistically insignificant, total pain score – 
indicating a T score of 1.18 and a p-value of 0.24 (Table 6)
 3
. The authors found it important to 
note that the maximum effectiveness of the heat patch is 8 hours. It is also important to note that 
only 79% of the initial participants were eligible and completed the study
3
.  
Table 6: 2012 Navvabi Rigi Study: Student T Test comparing Ibuprofen vs. Heat Patch  
T Test 1.18 
P 
Value 
0.24 
 
DISCUSSION 
This systematic review used three randomized control trials to assess the effectiveness of topical 
heat in pain relief associated with dysmenorrhea compared to oral non-steroidal anti-
inflammatory drugs. Two of the three studies included in this review showed significantly 
greater pain relief when using topical heat as compared to oral NSAIDs
1,2
. One study, however, 
showed no statistical significantly difference between the two treatments when measuring total 
current pain at hour 8
3
. It is important to note however, that these studies had some limitations.  
The 2001 Akin et. al study included only 84 women, which is not expected to accurately 
represent an entire population
1
. Furthermore, the 2004 Akin et. al study and the 2012 Navvabi 
Rigi study only had 367 and 147 women total in each of their studies, respectively
2,3
. The other 
limitation of these studies is that none of the studies were double-blinded. Participants would be 
aware if they were only being treated with a heat patch vs. pill
3
 or a heated vs. unheated patch
1,2
 
which made double-blinding difficult. It is also important to note that prior studies have showed 
that pharmacotherapy is general ineffective in treating dysmenorrhea in 20-25% of the 
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population
3
. Also, since these RCTs studied pain, it is important to remember that individuals 
have varying pain tolerances and this was not accounted for during randomization in each of the 
three studies. Lastly, it is also important to remember that two of the three studied ibuprofen as 
the oral NSAID of choice, while one used acetaminophen. Additionally, all three studies used 
different dosing of the oral NSAIDs which could have resulted in different results among the 
studies.  
CONCLUSIONS 
The purpose of this systematic review is to determine whether or not topical heat patches are 
more effective at relieving pain associated with dysmenorrhea than OTC NSAIDs (Ibuprofen 
400 mg PO Q8h or Acetaminophen 500mg PO Q6h) in menstruating women 18 and over.  The 
results of the three randomized control trials are inconclusive. The two studies performed by 
Akin et. al showed that patients treated with topical heat patches have statistically significant 
greater pain reduction that those taking oral NSAIDs
1,2
. A study by Navvabi Rigi et. al, however, 
showed no statistically significant difference in pain relief between patient using topical heat 
patches versus oral NSAID
3
.  
Due to the high prevalence of dysmenorrhea
3
, low incidence of adverse event of using topical 
heat patches
2
 and relatively low cost of heat patches
3
, it would be advantageous to continue with 
further studies on this topic. Further studies should work to blind participants, include larger 
sample sizes, and take pain tolerance into account when randomization the sample.  
 
 
 REFERENCES 
1. Akin MD, Weingand KW, Hengehold DA, Goodale MB, Hinkle RT, Smith RP. 
Continuous low-level topical heat in the treatment of dysmenorrhea. Obstet Gynecol. 
2001; 97(3):343-9. 
 
2. Akin M, Price W, Rodriguez G, Erasala G, Hurley G, Smith RP. Continuous, low-level, 
topical heat wrap therapy as compared to acetaminophen for primary dysmenorrhea. J 
Reprod Med. 2004;49(9):739-45. 
 
 
3. Navvabi rigi S, Kermansaravi F, Navidian A, et al. Comparing the analgesic effect of 
heat patch containing iron chip and ibuprofen for primary dysmenorrhea: a randomized 
controlled trial. BMC Womens Health. 2012;12:25. 
 
4. Dysmenorrhea.  Medscape Website. http://emedicine.medscape.com/article/253812-
overview#a0101 . Accessed October 6, 2014. 
 
 
 
